Growth in liquid media is the gold standard for detecting microorganisms associated with bloodstream infections. The Gram stain provides the first clue as to the etiology of infection, with phenotypic identification completed 1 or 2 days later. Providing more detailed information than the Gram stain can impart, and in less time than subculturing, would allow the use of more directed empirical therapy and, thus, reduce the patient's exposure to unnecessary or ineffective antibiotics sooner. The study had two objectives, as follows: (i) to identify new targets to improve our ability to differentiate among certain enteric gram-negative rods or among certain Streptococcus species and (ii) to determine whether real-time PCR and pyrosequencing could as accurately identify organisms directly from positive blood culture bottles as culture-based methods. Two hundred and fifty-five consecutive positive blood culture bottles were included. The results showed a high level of agreement between the two approaches; of the 270 bacteria isolated from the 255 blood culture bottles, results for pyrosequencing and culture-based identifications were concordant for 264/270 (97.8%) bacteria with three failed sequences, and three sequences without match. Additionally, compared to the universal 16S rRNA gene target, the new 23S rRNA gene targets greatly improved our ability to differentiate among certain enteric gram-negative rods or among certain Streptococcus species. In conclusion, combining real-time PCR and pyrosequencing provided valuable information beyond that derived from the initial Gram stain and in less time than phenotypic culturebased identification. This strategy, if implemented, could result in a more directed empirical therapy in patients and would promote responsible antibiotic stewardship.Growth in culture is the gold standard for detecting microorganisms present in the bloodstream (7, 24). Although automated blood culture systems have shortened the time needed to detect growth of an organism, we continue to rely heavily on the Gram stain result for the initial information about the organism's identity. This information is then provided to the healthcare team and used to determine the type of empirical therapy that will be ordered for the patient. It is common to start a patient on one or more broad-spectrum antimicrobial drugs while awaiting the culture-based identification and antimicrobial susceptibility test results. Unfortunately, phenotypic identification requires a minimum of 1 to 2 days to complete and another day to perform susceptibility testing. Having a faster way to classify the microorganism(s) present within positive blood culture bottles would allow tailoring of empirical antibiotic therapy and, thus, reduce the patient's exposure to ineffective or unnecessary antibiotic(s) while awaiting susceptibility testing results.